NCT05126953

2-Hour Dispensing Evaluation of Samfilcon A Lenses With EPG01 Packaging Solution Compared to Commercially Available B+L Ultra Lenses

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: Bausch & Lomb Incorporated · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The objective of this 2 hour study is to evaluate the clinical performance of samfilcon A lenses with an alternate packaging solution (EPG01) compared to commercially available B+L Ultra lenses.

Conditions

• Contact Lens Wearer

Interventions

Type	Name	Description
DEVICE	samfilcon A Lenses with EPG01 Packaging Solution	samfilcon A Lenses with EPG01 Packaging Solution
DEVICE	Commercially Available B+L Ultra Lenses	Commercially Available B+L Ultra Lenses

Timeline

• Start date: 2021-09-21
• Primary completion: 2021-09-23
• Completion: 2021-09-23
• First posted: 2021-11-19
• Last updated: 2025-07-20
• Results posted: 2025-07-20

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study